Comparative Toxicogenomics Database (CTD): update 2021 is a dataset published in Nucleic Acids Research (2020). On theSindex it has a DataRank of 5.9, placing it in the top 3.4% of the data-sharing corpus. It has been cited 1,160 times, with 100 citing works in its 1-hop citation network. Its calibrated FAIR score is 62/100.
Ranks in the top 3% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
This score predates the current agent — it came from the earlier rubric, which blended repository metadata into the number and asked the model for a rating rather than an evidenced verdict. Re-evaluate the paper to score it against the current standards-anchored criteria, where every verdict is backed by a quote from the full text.
DOI present
datacite=0, pmcid=True, pmid=True
OpenAlex id present
The paper mentions use of controlled vocabularies and FAIRsharing registration but does not include machine-readable metadata or structured metadata in the paper itself.
Open Access
0 OA location(s)
The paper provides clear URLs for accessing the database, tools, and downloadable data files, and states the Creative Commons Attribution License for reuse.
linked_datasets=0, datacite=0
accessions=0, trials=0
The paper explicitly describes use of standard vocabularies (MeSH, GO, Uberon, Cell Ontology) and identifiers, and maps to community-accepted ontologies.
no license
downloads=0
no version chain
is_dataset
The paper specifies a CC BY 4.0 license and provides download links, but lacks a formal data availability statement, code availability, or reproducibility details.
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
1.1
From this paper's citation signal
Citation Network Contribution
4.8
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
National Institute of Environmental Health Sciences
Grant: R01 ES014065
National Institute of Environmental Health Sciences
Grant: R01 ES023788
National Institute of Environmental Health Sciences
Grant: P30 ES025128
NIEHS NIH HHS
Grant: U24 ES033155
National Institutes of Health
Grant: 1P30ES025128-01
Center for Human Health and the Environment
National Institutes of Health
Grant: 5R01ES023788-04
Advancing mechanism-based studies with cross-species chemical-phenotype data
National Institutes of Health
Grant: 5R01ES014065-04
Comparative Toxicogenomics Database (CTD)
National Institutes of Health
FWCI
54.94
Citation Percentile
1.0%
Influential Citations
65
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
Additional file 1 of NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
Additional file 2 of NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
Additional file 2 of NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
Additional file 3 of NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
Additional file 3 of NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
Additional file 4 of NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
Additional file 4 of NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
Additional file 2 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 2 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 5 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 5 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 1 of Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction
Additional file 1 of Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction
Additional file 1 of CircWalk: a novel approach to predict CircRNA-disease association based on heterogeneous network representation learning
Additional file 1 of CircWalk: a novel approach to predict CircRNA-disease association based on heterogeneous network representation learning
Additional file 2 of Exploring the biological function of immune cell-related genes in human immunodeficiency virus (HIV)-1 infection based on weighted gene co-expression network analysis (WGCNA)
Additional file 2 of Exploring the biological function of immune cell-related genes in human immunodeficiency virus (HIV)-1 infection based on weighted gene co-expression network analysis (WGCNA)
Additional file 1 of Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer
Additional file 1 of Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer